Project Introduction

Shandong Huaxi Haiyu BioPharm, a leading CDMO specializing in mRNA vaccines and cell therapy media, faced critical steam supply challenges during its 2023 GMP facility expansion in Jinan. Their legacy oil-fired boilers (installed 2015) struggled with frequent pressure drops below 0.8 MPa during peak production of lipid nanoparticles, risking batch failures. With Shandong’s 2024 emission thresholds mandating ≤15 mg/m³ particulate matter, the company urgently required a high-capacity ​​20t/h gas steam boiler​​ compatible with ISO Class 7 cleanroom adjacencies.

Product Advantages

The WNS20-1.25-Q(θ7) gas steam boiler redefines large-scale pharmaceutical steam supply with its θ7 combustion chamber geometry, a patented design that amplifies thermal radiation efficiency by 18% while maintaining 99.2% fuel utilization – a benchmark unmatched in 20-ton class boilers. Engineered for precision-demanding bioprocessing, its full-radius steam drum eliminates condensate formation even during rapid load shifts, ensuring unbroken 134℃ saturation temperatures critical for sterilizing mRNA vaccine filling lines. The structural resilience shines in cleanroom environments: shock-absorbing alloy frames suppress vibrations to 2.5 mm/s, preventing harmonic interference with adjacent ISO Class 7 HVAC systems. Beyond raw performance, embedded IoT modules autonomously track burner wear and water chemistry, slashing maintenance downtime by 83% through AI-driven failure prediction – a feature validated during Huaxi Haiyu’s 72-hour stress tests simulating simultaneous lyophilizer and CIP operations.